Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized Double-blind Placebo-controlled Study of KHK4827 in Plaque Psoriasis
jRCT2080221977Phase 2
- Sponsor
- Kyowa Kirin
- Start
- Dec 2012
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in plaque psoriasis comparing KHK4827 with Placebo (2 arms).
02
Drugs
brodalumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on jRCT2080221977.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221977.